LHYFE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.22 EUR | 0.00% |
|
+1.56% | -16.27% |
| Mar. 28 | Lhyfe: aiming to accelerate profitability | CF |
| Mar. 28 | Lhyfe SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Capitalization 1 | 414.2 | 202 | 202 | - |
| Enterprise Value (EV) 1 | 292 | 241.3 | 241.4 | 331 |
| P/E ratio | -12.4 x | -7.2 x | -5.12 x | -4.61 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 727 x | 183 x | 15.5 x | 5.53 x |
| EV / Revenue | 512 x | 183 x | 18.6 x | 9.06 x |
| EV / EBITDA | -17.2 x | -8.59 x | -8.02 x | -12.8 x |
| EV / FCF | -11 x | -2.06 x | -2.15 x | -2.69 x |
| FCF Yield | -9.1% | -48.4% | -46.6% | -37.1% |
| Price to Book | 2.39 x | - | 3.04 x | 6.39 x |
| Nbr of stocks (in thousands) | 47,879 | 47,868 | 47,868 | - |
| Reference price 2 | 8.650 | 4.220 | 4.220 | 4.220 |
| Announcement Date | 3/22/23 | 3/28/24 | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | - | 0.57 | 1.317 | 13 | 36.55 |
| EBITDA 1 | - | -17 | -28.1 | -30.1 | -25.9 |
| EBIT 1 | - | -18.16 | -33.97 | -37.9 | -38.25 |
| Operating Margin | - | -3,185.09% | -2,579.65% | -291.54% | -104.65% |
| Earnings before Tax (EBT) 1 | - | -25.81 | -32.75 | -43.2 | -53.3 |
| Net income 1 | -8.724 | -25.82 | -33.49 | -39.6 | -43.95 |
| Net margin | - | -4,529.65% | -2,542.75% | -304.62% | -120.25% |
| EPS 2 | -0.4500 | -0.7000 | -0.7000 | -0.8250 | -0.9150 |
| Free Cash Flow 1 | - | -26.57 | -77.15 | -112.4 | -123 |
| FCF margin | - | -4,661.05% | -7,715% | -865% | -336.39% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 4/22/22 | 3/22/23 | 3/28/24 | - | - |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 39.4 | 129 |
| Net Cash position 1 | - | 122 | 42.7 | - | - |
| Leverage (Debt/EBITDA) | - | - | - | -1.309 x | -4.981 x |
| Free Cash Flow 1 | - | -26.6 | -77.2 | -112 | -123 |
| ROE (net income / shareholders' equity) | - | -40.5% | - | -42.7% | -70.5% |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | 3.620 | - | 1.390 | 0.6600 |
| Cash Flow per Share 2 | - | -0.4100 | -0.8000 | - | - |
| Capex 1 | - | 11.5 | 44.2 | 60 | 50 |
| Capex / Sales | - | 2,019.82% | 4,420% | 461.54% | 136.8% |
| Announcement Date | 4/22/22 | 3/22/23 | 3/28/24 | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
4.22
EUR
Average target price
5.533
EUR
Spread / Average Target
+31.12%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.27% | 216M | |
| +8.64% | 136B | |
| -2.19% | 77.98B | |
| +0.69% | 75.38B | |
| -8.92% | 66.47B | |
| +61.15% | 59.36B | |
| +4.97% | 44.9B | |
| +7.34% | 42.26B | |
| 0.00% | 41.94B | |
| +3.96% | 37.31B |
- Stock Market
- Equities
- LHYFE Stock
- Financials Lhyfe
